Trans-jugular AngioJet rheolytic thrombectomy for acute deep vein thrombosis: Alternative to overcome the limitation of patient’s position

Abstract

Background:

To introduce a transjugular retrograde approach for AngioJet rheolytic thrombectomy (RT) just after transjugular placement of inferior vena cava filter (IVCF) to treat acute deep vein thrombosis (DVT).

Methods:

From September 2018 to April 2019, transjugular Angiojet RT using pulse spray method was performed just after transjugular placement of IVCF in five patients (M:F = 3:2, mean age 70 years). Patients less than 165 cm in height with acute (<14 days) iliofemoral DVT were unable to assume a prone position. All patients underwent pre- and postprocedural venography to estimate thrombus reduction grade. Computed tomography angiograms at 3 and 6 months postoperative were compared with baseline scans. Post-thrombotic syndrome (PTS) symptoms were evaluated according to Villalta score during 12-month follow-up.

Results:

Mean procedure time for all procedures was 1.4 h. Thrombus was completely reduced in three patients and 50% to 99% reduction was noted in the other two. No patients had major complications during the hospital stay and follow-up period. Distal migration of IVCF occurred in one patient during the procedure and immediate IVCF repositioning was performed. No DVT remained in follow-up computed tomography scans of all patients. PTS did not develop in any patients during the follow-up period.

Conclusion:

In patients who are unable to assume a prone position, a transjugular retrograde approach with AngioJet RT just after transjugular placement of IVCF to treat acute lower extremity DVT was a time-saving and easy alternative. During the procedure, attention to the guiding catheter position and AngioJet device movement was required to avoid affecting the IVCF.

Keywords

Lower extremity venous thrombosis transjugular retrograde venous access rheolytic thrombectomy

Get full access to this article

View all access options for this article.

References

White

RH.

The epidemiology of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1): 14–18.

Kearon

Akl

EA.

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 2014; 123(12): 1794–1801.

Kyrle

Eichinger

Deep vein thrombosis. Lancet 2005; 365(9465): 1163–1174.

Boc

Vene

Stalc

, et al. Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism. Thromb Res 2014; 133(6): 1011–1015.

Hughes

Stein

Matta

Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review. Thromb Res 2014; 134(6): 1182–1185.

Ageno

Squizzato

Garcia

, et al. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 2006; 32(7): 651–658.

Horlander

Mannino

Leeper

KV.

Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003; 163(14): 1711–1717.

Bond

Cohen

Comerota

, et al. Surgical treatment of moderate-to-severe post-thrombotic syndrome. Ann Vasc Surg 2013; 27(2): 242–258.

Farrell

Sutter

Tavri

, et al. Incidence and interventions for post-thrombotic syndrome. Cardiovasc Diagn Ther 2016; 6(6): 623–631.

10.

Rabinovich

Kahn

SR.

The postthrombotic syndrome: current evidence and future challenges. J Thromb Haemost 2017; 15(2): 230–241.

11.

O’Connor

Lookstein

Endovascular interventions for venous disease. Tech Vasc Interv Radiol 2018; 21(2): 55–64.

12.

Sista

Vedantham

Kaufman

, et al. Endovascular interventions for acute and chronic lower extremity deep venous disease: state of the art. Radiology 2015; 276(1): 31–53.

13.

Behravesh

Hoang

Nanda

, et al. Pathogenesis of thromboembolism and endovascular management. Thrombosis 2017; 2017: 3039713.

14.

Kearon

Akl

Comerota

, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141(Suppl 2): e419S–e496S.

15.

Kearon

Natural history of venous thromboembolism. Circulation 2003; 107(23 Suppl 1): 122–130.

16.

Comerota

AJ.

Deep venous thrombosis and postthrombotic syndrome: invasive management. Phlebology 2015; 30(Suppl 1): 59–66.

17.

Utne

Tavoly

Wik

, et al. Health-related quality of life after deep vein thrombosis. Springerplus 2016; 5(1): 1278.

18.

Garcia

Lookstein

Malhotra

, et al. Endovascular management of deep vein thrombosis with rheolytic thrombectomy: final report of the prospective multicenter PEARL (Peripheral Use of AngioJet Rheolytic Thrombectomy with a Variety of Catheter Lengths) registry. J Vasc Interv Radiol 2015; 26(6): 777–785.

19.

Jaff

McMurtry

Archer

, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123(16): 1788–1830.

20.

Meissner

Gloviczki

Comerota

, et al. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012; 55(5): 1449–1462.

21.

Vedantham

Sista

Klein

, et al. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2014; 25(9): 1317–1325.

22.

Koksoy

Yilmaz

Basbug

, et al. Pharmacomechanical thrombolysis of symptomatic acute and subacute deep vein thrombosis with a rotational thrombectomy device. J Vasc Interv Radiol 2014; 25(12): 1895–1900.

23.

Vedantham

Endovascular procedures in the management of DVT. Hematology Am Soc Hematol Educ Program 2011; 2011(1): 156–161.

24.

Baker

Samuels

Benenati

, et al. Ultrasound-accelerated vs standard catheter-directed thrombolysis–a comparative study in patients with iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2012; 23(11): 1460–1466.

25.

Blackwood

Dietzek

AM.

Pharmacomechanical thrombectomy: 2015 update. Expert Rev Cardiovasc Ther 2016; 14(4): 463–475.

26.

Kim

Patra

Paxton

, et al. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006; 17(7): 1099–1104.

27.

Vedantham

Goldhaber

Kahn

, et al. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J 2013; 165(4): 523–530.e3.

28.

Kearon

Akl

Ornelas

, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149(2): 315–352.

29.

Dumantepe

Uyar

The effect of Angiojet rheolytic thrombectomy in the endovascular treatment of lower extremity deep venous thrombosis. Phlebology 2018; 33(6): 388–396.

30.

Song

Liu

Zeng

, et al. The efficacy and safety of angioJet rheolytic thrombectomy in the treatment of subacute deep venous thrombosis in lower extremity. Ann Vasc Surg 2019; 58: 295–301.

31.

Jaffe

Newcomb

York

, et al. Venous valvular assessment after retrograde catheterization. J Vasc Interv Radiol 1996; 7(4): 595–597.

32.

Rhodes

Cho

Gloviczki

, et al. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000; 31(6): 1193–1205.

33.

DeYoung

Minocha

Inferior vena cava filters: guidelines, best practice, and expanding indications. Semin Intervent Radiol 2016; 33(2): 65–70.

34.

Lin

Zhou

Dardik

, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192(6): 782–788.

35.

Dumantepe

Tarhan

Yurdakul

, et al. US-accelerated catheter-directed thrombolysis for the treatment of deep venous thrombosis. Diagn Interv Radiol 2013; 19(3): 251–258.